Eli Lilly and Company / AtaiBeckley Inc. (LLY) — Bloomberg reported that Eli Lilly was nearing an agreement to acquire psychedelic drugmaker AtaiBeckley, sending AtaiBeckley shares higher on the prospect of a Big Pharma entry into the sector.
The report set up the following day's formal announcement. It signaled growing large-cap pharmaceutical conviction in psychedelic therapies for depression.
Source: bloomberg.com
For the rest of that week's sector news, read our week in review.